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The effects of estradiol dipropionate (EDP) or calcium
glucoheptonate (Ca) on the morphology and stereology of the PRL
cells in 14-month-old Wistar female rats were studied. The animals were
treated daily with EDP in the dose of 0.625 mg/kg b.w. or calcium
glucoheptonate (Ca; 11.4 mg/kg b.w.) for two weeks. The controls were
injected with vehicle alone by the same schedule. Mammotrophs (PRL
cells) were immunocytochemically localized by the PAP method. Blood
PRL concentration was determined by Delfia procedure. In animals
treated with EDP the volume of both, PRL cells and their nuclei, as well
as the volume densities were significantly (p<0.05) increased by 17%,
9% and 38%, respectively, in comparison with the controls. In animals
treated with Ca all morphometric parameters were insignificantly
(p>0.05) decreased compared to control rats. Serum concentration of
PRL was significantly increased (p<0.05) by 17% after estradiol
treatment, but in Ca-treated females this parameter was insignificantly
(p>0.05) changed by 2% compared to controls. Based on these
results, it can be concluded that EDP expresses a strong stimulatory
effect on the morphology and function of pituitary PRL cells.
Key words: PRL, mammotrophs, estradiol, calcium, middle-aged,
female rats
INTRODUCTION
Prolactin (PRL) is a polypeptide hormone that is synthesized and secreted
from specialized cells of the anterior pituitary gland, lactotrophs or mammotrophs
(Freeman et al., 2000). Chatelain et al. (1979) reported that mammotrophs (PRL
cells) were detected on day 21 of gestation, but Watanabe and Haraguchi (1994)
reported that PRL cells were first detected postnatally. The difference in the
number and size of PRL cells in pituitary glands between adult rats may partially
result from the sex difference in the mitotic activity of PRL cells during adult lifetime
(Takahashi et al., 1984, 1992).
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In rat’s pars distalis, estradiol immunopositivity was observed in the nucleus
of all cell types, including acidophils, basophils and chromophobes. According to
Murai and Ben-Jonathan (1990) estradiol plays a crucial role in PRL release.
Estrogen increased the percentage of Type I PRL cells, considered to be a mature
type of PRL cells and decreased the percentage of immature Type II and III PRL
cells (Takahashi and Kawashima, 1987).
The hypothalamo-pituitary system has a central importance in the
regulation of biological mechanisms of aging. Some of the hormones secreted
from the anterior pituitary, including PRL, are related to the potency of survival
during the aging process (Ooka, 1993). Age-related changes in hormonal
secretion can be secondary to physiological changes in the circadian and
seasonal rhythm, or in the frequency or height of hormonal pulses (Mooradian,
1993). The percentage of PRL cells and PRL secretion significantly increased in
female rats with age (Takahashi, 1992). On the contrary, reproductive decline in
female rats begins in the same period, i.e. the function of gonadotrophic axis as
well as the estrogen level were decreased during middle age (Lovren et al., 1999).
In pituitary cells secretory processes are controlled by regulatory molecules
such as inorganic ions, Ca2+, vitamins, metabolites and growth hormone (Perez
et al., 1995). Calcium acts as an extracellular and intracellular messenger to
regulate a diverse array of cellular functions (Zivadinovic et al., 2002).
Hormonal profiles during middle age are dramatically different from these
found during the estrus cycle. Therefore, the aim of this study was to evaluate the
morphometric and morphological characteristics of immunopositive PRL cells in
middle-aged female rats after chronic estradiol dipropionate or calcium
glucoheptonate treatment.
MATERIAL AND METHODS
Treatment of animals
Wistar 14-month-old female rats, bred at the Institute for Biological
Research, Belgrade, were used. The animals were kept under a 12 : 12 h light-
dark cycle, at 22±2 oC. They had free access to food (produced by Veterinarski
zavod Subotica, Subotica, Serbia) and water. Middle-aged females were i.p.
receiving estradiol dipropionate (EDP; 0.625 mg/kg b.w., ICN Galenika, Belgrade,
Serbia), or i.m. calcium glucoheptonate (Ca; 11.4 mg/kg b.w. Novartis, Nypon,
Switzerland) every day for two weeks. The control rats were injected with the
corresponding vehicle by the same schedule. All animals, 5 rats per each group,
were sacrificed in deep anesthesia 24 h after the last injection. Experimental
protocols were approved by the Local Animal Care Committee and conformed to
the recommendations given in "Guide for the Care and Use of Laboratory Animals"
(1996 National Academy Press, Washington D.C.). Cytological examinations of
vaginal smears started at 13 months of age. The estrous cycle of these females
was irregular with long estrus stages (persistent vaginal cornification) interspaced
by one or two days of proestrus or diestrus.
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Light microscopy and immunocytochemistry
Pituitary glands were excised, fixed in Bouin’s solution for 48 h and
embedded in paraffin. Serial 5 m thick tissue sections were deparaffinized in
xylol and serial alcohol. Three pituitary sections per animal, from dorsal, medial
and ventral parts were prepared for immunocytochemical staining. Pituitary
hormones were localized by the peroxidase-antiperoxidase-complex (PAP)
method of Sternberger et al. (1970). Endogenous peroxidase activity was blocked
by incubation in 9 mmol/L hydrogen peroxide in methanol for 30 min at room
temperature. Before application of specific primary antisera, nonspecific
background staining was minimized by incubation of the sections with non-
immune, porcine serum diluted with phosphate buffered saline pH 7.4 (PBS) for
60 min. Sections were then overlaid with the appropriate dilutions of the specific
primary antibodies-hPRL-antisera, ("Dako A/S", Glostrup, Denmark) at 4 oC for
48 h. After washing in PBS, sections were incubated for another 60 min with the
second antibody-swine-antirabbit IgG for 45 min, rinsed again with PBS for 10 min
and incubated with rabbit PAP serum for 45 min. Antibody localization was
visualized by incubating the sections in Tris-HCl buffered saline (0.05 mol/L, pH
7.4) supplemented with 3,3-diaminobenzidine tetrachloride (DAB: Serva) and
9 mmol/L hydrogen peroxide. Slides were thoroughly washed under running tap
water, counterstained with hematoxylin and mounted in Canada balsam
("Alkaloid", Skopje, Former Yugoslav Republic of Macedonia). Negative control
sections were incubated without primary antisera or by substituting non-immune
rabbit serum for the primary antiserum.
Morphometry
Measurements were performed on the widest portion of the pituitary gland
and immunocytochemically-labelled PRL cells were analyzed by the M42 test
system according to Weibel (1979). For the calculations of the cell and nuclear
volumes the formula of Weibel (1979) was used. The mean value for each rat was
computed from 50 fields from the three widest sections (n=150 measurements
per/rat). Sections from the same pituitary level (ventral, medial and dorsal) of the
control and experimental groups were compared.
Digital images were made on a DM RB Photomicroscope (Leica, Wetzlar,
Germany) with a JVC TK 1280E Video Camera (Leica). For image acquisition
Qwin program (Leica) was used.
Biochemical analyses
Serum concentrations of PRL in control and treated rats were measured by
the Delfia method (hPRL-Delfia kits, LKB, Turkey, Finland).
Statistical analyses
Biochemical and morphometric data obtained from each group were
averaged, and the standard deviation of the mean was calculated. A one-way
analysis of variance (ANOVA), followed by the multiple range test of Duncan
(Pharmacological Calculation System, 1986) was used for statistical comparisons
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between groups. A probability value of 5% or less was considered statistically
significant.
RESULTS
In female rats treated with either EDP or Ca-glucoheptonate, body weight
was significantly decreased (p<0.05) in comparison with the controls. However,
the absolute and relative pituitary weights in either of the treated groups were
significantly increased (p<0.05) in comparison with the corresponding control
rats (Table 1).
Table 1. Effects of multiple EDP or Ca-glucoheptonate treatment on body weight,
absolute and relative pituitary weights in middle-aged female rats
Experimental
group
Body weight
(g)
Absolute pituitary
weight (mg)
Relative pituitary
weight (%)
Control 336 ± 19.8 17.3 ± 1.7 5.3 ± 0.6
EDP
307 ± 11.2*
(-9%)
36.4 ± 3.9*
(+110%)
11.8 ± 1.6*
(+123%)
Ca
306 ± 2.8*
(-9%)
30.5 ± 3.5*
(+76%)
7.4 ± 0.8*
(+40%)
The values are the means ± SD (n=5/group). * p<0.05 vs. controls.
Immunocytochemically labelled mammotrophs in the control pituitaries
were polygonal, elongated in shape, with a spherical centrally located nucleus
(Fig. 1A). Mammotrophs were sparse in the anterior-ventral portion of the gland.
Large oval gonadotrophic cells usually surrounded PRL cells. In estradiol-treated
female rats mammotrophs were elongated, irregularly shaped, with more intense
black secretory granules (Fig. 1B). In the females treated with Ca the PRL cells
were smaller and irregularly shaped, compared with the controls (Fig. 1C).
The morphometric parameters, i.e. the volume of the mammotrophs and
their nuclei, as well as volume density of these cells after EDP or Ca treatment are
shown in Table 2.
Volumes of PRL cells and their nuclei, as well as volume density of
mammotrophs, were significantly (p<0.05) increased in EDP-treated rats by 17%,
9% and 38% respectively, in comparison with controls. In animals treated with Ca
the volume of the mammotrophs, their nuclei and the volume density were not
significantly (p>0.05) decreased compared to controls.
Serum concentration of PRL was significantly increased (p<0.05) by 17%
after estradiol treatment, but in Ca-treated females serum PRL level was not
significantly (p>0.05) changed in comparison with control rats (Fig. 2).
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Figure 1. Immunocytochemically identified mammotrophs in: (A) control rats; (B) EDP, and
(C) Ca-glucoheptonate treated rats. (Bar - 25 m)
C
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Table 2. Effects of multiple EDP or Ca-glucoheptonate treatment on morphometric
features of the mammotrophs in middle-aged female rats
Experimental
group
Volume of the
mammotrophs (m3)
Volume nuclei of the
mammotrophs (m3)
Volume density of the
mammotrophs (%)
Control 1180 ± 14.1 124 ± 5.6 35.8 ± 0.8
EDP
1380 ± 0.1*
(+17%)
135 ± 0.6*
(+9%)
49.4 ± 2.1*
(+38%)
Ca
1155 ± 63.6
(-2%)
116 ± 5.7
(-6%)
33.5 ± 2.12
(-6%)
The values are the means ± SD (n=5/group). * p<0.05 vs. controls.
DISCUSSION
Ageing is associated with a myriad of functional and anatomical changes of
the endocrine glands, usually as a result of programmed cell death, autoimmune-
mediated destruction of the gland, or neoplastic transformation of glandular
tissue (Mooradian, 1993). The hypothalamic-pituitary-adrenal (HPA) axis is an
autoregulating system with many modulatory mechanisms. Due to such
regulation, the circulating levels of glucocorticoids are highly variable, according
both to the spontaneous rhythmic fluctuations and to the responses towards
stressful conditions (Ferrari et al., 2001). The mechanisms underlying these
changes are variable. In previous studies, we have observed an activity reduction
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Figure 2. Serum concentration of PRL in middle-aged female rats treated with EDP or Ca-
glucoheptonate. Data are expressed as mean values ± SD (n=5/group);
*p<0.05 vs. control
of many pituitary cells, such as TSH- (Sekuli} et al., 1998), gonadotrophic- (FSH
and LH) (Lovren et al., 1999) and GH-cells (Milo{evi} et al., 2005) in middle-aged
rats. The structure and function of corresponding targets organs were also
changed in middle-aged and aged rats (Sekuli} and Lovren, 2000).
The results obtained throughout the present study clearly demonstrate that
multiple EDP doses given to middle-aged female rats resulted in an increase of
absolute and relative pituitary weights. This could be explained by an increased
number of mammotrophs, chromophobes (Panti}, 1995) and adrenocorticotropic
(ACTH) cells (Kosti} et al., 2003) as demonstrated in this study.
Results presented here demonstrate that pituitary mammotrophs were
larger in size, irregularly shaped, with more intensive immunostaining in estradiol-
treated female rats then in controls. Volumes of mammotrophs and their nuclei, as
well as volume density, were significantly increased in EDP-treated rats in
comparison with controls. Serum concentration of PRL was also significantly
increased by 17% after estradiol treatment. Takahashi and Kawashima (1987)
observed a significant age-related increase of the DNA content in mammotrophs
in rats of both sexes, but this increase was more conspicuous in the females than
in males. A significant increase in the number of mammotrophs, as well as in PRL
secretion was also observed by Takahashi et al. (1984) and Itoh et al. (2001) in
middle-aged females. Takahashi and Miyatake (1991) reported that estrogen
treatment significantly increased the mammotrophs volume density in male and
female rats. Estrogen stimulated the proliferation of mammotrophs type I, and
decreased percentages of type II and III cells (Takahashi, 1992). Type I PRL cells
contained irregularly shaped, large secretory granules with a diameter of 300-
700 nm; type II contained spherical granules with a diameter of 150-250 nm, while
type III cells contained small round granules with a diameter of 100 nm (Ozawa
and Kurosumi, 1989). Estrogen treatment for only 7 days may cause a significant
proliferation of lactotrophs by 70%, and this proliferation was concurrent with
higher serum and pituitary PRL levels (Mukdsi et al., 2004). The concentration of
PRL in the blood of female rats increases with age (Ooka, 1993). Metka et al.
(1994) reported that the estrogen-gestagen replacement therapy significantly
increased PRL level in menopausal women.
In the present study, we observed that multiple treatment of middle-aged
female rats with calcium resulted in a statistically insignificant decrease of all
morphometric parameters of mammotrophs, as well as blood serum PRL level. In
our earlier studies we have shown that chronic treatment of middle-aged female
rats with calcium reduced morphometric and functional characteristics of
gonadotrophic, TSH- and GH- cells (Sekuli} et al., 1998; Lovren et al., 1999;
Milo{evi} et al., 2005). Calcium is known to be an essential nutrient involved in a
number of metabolic processes and its phosphate salts provide mechanical
rigidity to bones and teeth, where 99% of the body's calcium occurs (Nordin,
1997). Calcium also controls numerous cell functions in general, including
pituitary cells. Zorec (1996) reported that a rise in cytosolic calcium ions
represents an important trigger for hormone secretion from pituitary cells.
@ivadinovi} et al. (2002) indicate the mechanisms underlying the critical role of
extracellular calcium on basal hormone secretion from anterior pituitary
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somatotrophs and lactotrophs. The majority of basal GH and PRL secretion was
an extracellular calcium dependent process, which is sensitive to blockage of
voltage-gated calcium influx through L-type channels (Cota et al., 1990).
It can be concluded that the multiple application of EDP to middle-aged
females results in increased morphological parameters of pituitary
mammotrophs. However, in calcium treated animals the morphological
characteristics of mammotrophs were not significantly changed.
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EFEKAT TRETMANA ESTRADIOLOM I KALCIJUMOM NA PROLAKTINSKE ]ELIJE U
ACIKLI^NIH @ENKI PACOVA
MILO[EVI] VERICA, STAR^EVI] VESNA, [O[I]-JURJEVI] BRANKA, FILIPOVI] B,
TRIFUNOVI] SVETLANA, RISTI] NATA[A, NESTOROVI] NATA[A,
MANOJLOVI] MILICA i SEKULI] MILKA
SADR@AJ
Ispitivani su efekti vi{ekratnih doza estradiol dipropionata (EDP) ili kalcijum
glukoheptonata (Ca) na morfolo{ke i stereolo{ke karakteristike mamotropnih
(PRL) }elija u acikli~nih `enki pacova. Acikli~ne `enke su svakodnevno tokom dve
nedelje dobijale 0,625 mg/kg tm EDP-a ili 11,4 mg/kg tm Ca. PRL }elije su imu-
nocitohemijski obele`avane PAP metodom. U `ivotinja tretiranih sa EDP-om za-
premina }elija i njihovih jedara kao i volumenska gustina signifikantno (p<0,05)
su bile pove}ane za 17%, 9% i 38% u pore|enju sa kontrolama. U `ivotinja tretira-
nih kalcijumom ispitivani morfometrijski parametri nisu bili zna~ajno (p>0,05)
promenjeni. Koncentracija PRL u serumu zna~ajno (p<0,05) je bila pove}ana (za
17%) posle tretmana estradiolom dok tretman kalcijumom nije izazvao zna~ajne
promene (2% u odnosu na kontrole). Na osnovu dobijenih rezultata mo`e se za-
klju~iti da EDP ima sna`an stimulatorni efekat na PRL }elije u hipofizi.
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